Zensai Pharmaceuticals Private Limited
About Zensai Pharmaceuticals Private Limited
Data last updated:
Zensai Pharmaceuticals Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 26 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U52311OR2014PTC018223. Its GSTIN is 21AAACZ7795G1Z1 (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nrusingha Charan Manasingha and Suryakant Pattnaik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 282/2394 Kalinga Nagar Patrapada, Bhubaneswar, Odisha, India – 751019.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.74 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹1.69 Lakh (net margin 12.3%) and EBITDA of ₹1.82 Lakh (EBITDA margin 13.3%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Zensai Pharmaceuticals Private Limited's registered office is in Bhubaneswar, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 282/2394 Kalinga Nagar Patrapada, Bhubaneswar, Odisha, India – 751019
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Zensai Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zensai Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zensai Pharmaceuticals Private Limited, buy the company report.
Financials of Zensai Pharmaceuticals Private Limited
FY 2025 filings availableZensai Pharmaceuticals Private Limited reported revenue of ₹13.74 Lakh (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 17% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.3% | ||||
| Net Profit Margin | 12.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zensai Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zensai Pharmaceuticals Private Limited
Zensai Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nrusingha Charan Manasingha | Director | 31 Aug 2016 | 10 Years 2 Months | Current |
| Suryakant Pattnaik | Director | 26 Aug 2014 | 12 Years 2 Months | Current |
| Dipti Prakash Pattanaik Also directs: Sai Bhagabati Multiprojects Private Limited | Director | 26 Aug 2014 | 12 Years 2 Months | Current |
Peer comparison
Zensai Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Decorum Pharmaceuticals Private Limited | ₹13.87 Lakh (FY 2024) | -5.0% | Patna, Bihar, India | |||
| Insta Life Pharmaceuticals Private Limited | ₹13.77 Lakh (FY 2025) | 114.0% | Dehradun, Uttarakhand, India | |||
| Samank Pharmaceuticals Private Limited | ₹13.75 Lakh (FY 2023) | 5.0% | Thane, Maharashtra, India | |||
| Zensai Pharmaceuticals Private Limitedthis company | ₹13.74 Lakh (FY 2024) | ₹1.69 Lakh | 12.3% | 17.0% | Bhubaneswar, Odisha, India | |
| Aryan Pharmaceuticals Pvt Ltd | ₹13.69 Lakh (FY 2022) | -59.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Zensai Pharmaceuticals Private Limited, buy the company report.
Auditor
Zensai Pharmaceuticals Private Limited is audited by DHARANI AND COMPANY CHARTERED ACCOUNTANTS for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHARANI AND COMPANY CHARTERED ACCOUNTANTS | FY 2017 | 329649E |
Shareholding
The shareholding of Zensai Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Zensai Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zensai Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zensai Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zensai Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAACZ7795G1Z1 | Odisha | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zensai Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zensai Pharmaceuticals Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Nrusingha Charan Manasingha was appointed as Director on 31 Aug 2016.
Frequently asked questions
Zensai Pharmaceuticals is an active private limited company based in Bhubaneswar, Odisha, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 26 August 2014 (12+ years old) and is registered under CIN U52311OR2014PTC018223.
Zensai Pharmaceuticals has 3 current directors:
- Nrusingha Charan Manasingha - Director
- Suryakant Pattnaik - Director
- Dipti Prakash Pattanaik - Director
The latest financial statements of Zensai Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zensai Pharmaceuticals is 21AAACZ7795G1Z1, registered in Odisha.
The CIN (Corporate Identification Number) of Zensai Pharmaceuticals is U52311OR2014PTC018223. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zensai Pharmaceuticals was incorporated on 26 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Zensai Pharmaceuticals by revenue are Decorum Pharmaceuticals Private Limited, Insta Life Pharmaceuticals Private Limited, Samank Pharmaceuticals Private Limited, Aryan Pharmaceuticals Pvt Ltd, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nrusingha Charan Manasingha was appointed as Director on 31 Aug 2016. Dipti Prakash Pattanaik was appointed as Director on 26 Aug 2014. Suryakant Pattnaik was appointed as Director on 26 Aug 2014.
The registered office of Zensai Pharmaceuticals is at Plot No – 2822394 Kalinga Nagar Patrapada, Bhubaneswar, Odisha, India – 751019.
Zensai Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Zensai Pharmaceuticals is compliant as of 04 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
